Recently Released Market Study: Advanced Malignancy - Pipeline Review, H2 2012
Global Markets Direct's, 'Advanced Malignancy - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Advanced Malignancy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Advanced Malignancy. Advanced Malignancy - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations...
View full press release